Skip to main content
PLOS One logoLink to PLOS One
. 2021 Mar 19;16(3):e0248864. doi: 10.1371/journal.pone.0248864

Prevalence of psychiatric disorders in Norwegian 10-14-year-olds: Results from a cross-sectional study

Tormod Bøe 1,2,*, Einar Røshol Heiervang 3,4, Kjell Morten Stormark 2,5, Astri J Lundervold 6, Mari Hysing 1,2
Editor: Ehsan U Syed7
PMCID: PMC7978367  PMID: 33740026

Abstract

Youth mental health problems is the leading cause of disability worldwide and a major public health concern. Prevalence rates are needed for planning preventive interventions and health care services. We here report Norwegian prevalence estimates for youth mental disorders based on findings from the Bergen Child Study cohort. A web-based psychiatric interview; the Development and Well-Being Assessment, was completed by parents and teachers of 2,043 10-14-year-olds from the city of Bergen, Norway. Post-stratification weights were used to account for selective participation related to parental educational in the estimation of prevalence rates. Prevalence rates are presented for the whole sample and stratified by gender and age. The overall population weighted estimate suggests that 6.93% (95% CI 5.06–9.41) of the children met DSM-IV diagnostic criteria for one or more psychiatric disorders. There were no robust indications of age- or gender-related differences in the prevalence. 11.4% of the children fulfilled criteria for more than one diagnosis. The most common comorbid conditions were ADHD and disruptive disorders. The prevalence of psychiatric disorders was relatively low among Norwegian 10-14-year-olds, compared to published worldwide prevalence estimates. This is in line with estimates from prior studies from the Nordic countries. These findings raise important questions about the origins of different prevalence rates for psychiatric disorders between societies. The findings also illustrate the importance of locally driven epidemiological studies for planning preventative efforts and appropriately scaling mental health services to meet the need of the population.

Introduction

Mental health problems among children are a major public health concern and the leading cause of disability worldwide [1]. Further, mental health problems in adulthood often have their origin in childhood and adolescence [2], underscoring the need for reliable prevalence data. Still, the global coverage of prevalence data for children is limited [3]. The assumed increase in childhood psychiatric disorders over the last decades has been based on official clinical registries [4], but these are susceptible to reporting practices and may therefore not render reliable prevalence estimates [5,6]. Estimates from administrative registers may also be biased since groups with lower socioeconomic status are under-represented [7,8]. Actual prevalence may also be higher because children with mental health problems go undetected and are thus left without treatment options [9,10]. We therefore need population-based epidemiological studies in order to obtain realistic prevalence estimates as a base for offering preventive interventions and scaling of health services.

A meta-analysis of 41 studies from 27 countries produced an overall worldwide prevalence estimate of 13.4% for child mental health disorders, but with large heterogeneity across studies and countries [11]. Differences may result from a number of methodological differences; e.g. sampling procedure, diagnostic instrument, informant type [12], the time frame (three [13], six [12] or 12 months [14]), and the estimation method. However, it may also reflect true variations in prevalence rates a across societies or age groups. Results from a former wave of the present longitudinal study, conducted when the cohort were 7–9 years old, indicated a 7.0% weighted prevalence for psychiatric disorders, with a high rate of comorbid conditions [10]. This was well below the overall world prevalence reported by Polanczyk et al. in their recent meta-analysis [11], but in line with previous studies from Scandinavian countries [1518].

The rate of psychiatric disorders may also vary by gender and age. While boys show a higher frequency of Attention Deficit Hyperactivity Disorder (ADHD) and disruptive disorders than girls [1922], there is a predominance of girls having emotional [12,23] and eating disorders [24]. The developmental changes during pre-adolescence may also give rise to changes in rates for mental disorders. It has for example been shown that ADHD is more frequent among younger children whereas conduct and mood disorders are more frequent in early adolescence [23]. Still, many studies present overall estimates for the whole childhood period, not specifying prevalence rates for the different age groups [11,12].

There is also an association between socioeconomic factors and higher frequencies of mental health problems in children and youth [2527]. Low parental education levels and poorer financial status are also predictors for non-participation in surveys [28]. Thus, if epidemiological studies do not account for selective participation related to higher socioeconomic status (SES), prevalence estimates may be biased [29,30].

The aim of the present study is to present prevalence of psychiatric disorders in a Norwegian population-based sample of early adolescent boys and girls. We hypothesized that 1) estimates would be similar to what was reported for the same cohort at a younger age, 2) that boys would show more externalizing problems and girls more internalizing problems, and 3) an overall increase in the prevalence of emotional and conduct problems in the older age groups.

Methods

Participants and procedure

The current analyses are based on data from the Bergen Child Study, a series of cross-sectional multi-phase surveys of children born between 1993 and 1995 living in Bergen, the second largest city in Norway (see https://www.norceresearch.no/en/projects/the-bergen-child-study for more information).

The present study uses data from the second cross-sectional study (wave two) carried out in 2006, when the children were in fifth to seventh grade (10–14 years old), in a target population of 9,218. Mean age was 12.5 (SD = 0.8, range = 10.4–14.2), with 52% of the sample being female. In the first questionnaire phase of the data collection, parents, children and teachers completed on-line questionnaires for 5,661 children (teacher data from the screening phase is not included in the following study). Parents who took part in the questionnaire phase were also invited to complete a second phase, which involved an on-line psychiatric interview; the Development and Well-Being Assessment [31], see flowchart in Fig 1.

Fig 1. Participant flow through the two phases of the second wave of the Bergen Child Study.

Fig 1

The DAWBA was administered through a web-based system, and parents and teachers provided information about the children using a special website after logging in with a unique identification number and password. From the 2,043 parents who logged into the on-line interview, 1,364 completed all sections and forms the DAWBA sample in the current study. The study was approved by the Regional Committee for Medical Research Ethics in Western Norway (approval number 062–06) and by the National Data Inspectorate. Participants gave written informed consent and parents and guardians consented on behalf of their children.

Instruments

Questionnaire phase

Among the instruments included in the questionnaire phase was the Strengths and Difficulties Questionnaire [32,33]. The SDQ is a brief screening questionnaire including 25 items assessing emotional symptoms, conduct problems, hyperactivity-inattention, peer problems and prosocial behaviours. The SDQ total problems score is computed by adding all items except those measuring prosocial behaviours. In the current study, the parent completed SDQ was used to assess the representativeness of participants in the psychiatric assessment phase (i.e. DAWBA sample) compared to those participating in the first phase only.

Parents provided details about their education level (categorized into an ordinal variable with four levels: “Elementary”, “High school”, “University/college less than or equal to four years” and “University/college more than four years”). Information about child gender and age was obtained from their personal identification number.

Psychiatric assessment

The Development and Well-Being Assessment (DAWBA) is a well-established psychiatric interview [31] and was administered on-line to parents and teachers. The DAWBA is a partially structured interview, containing screening questions with fixed response options, supplemented by open-ended questions if problems are reported. Respondents typed their answers, giving examples and details about level of severity (functional impairment) in text boxes. A highly trained and experienced clinical rater (ERH) subsequently assigned psychiatric diagnoses, with the help of the DAWBA program rater screens [34,35]. More details about the DAWBA is available on the website: http://dawba.info/a0.html. The current study made use of DSM-IV diagnostic categories.

Statistical analyses

Two prevalence estimates were produced: one unweighted estimate, and one estimate using post-stratification weights. Post-stratification weights were created using auxiliary information about the marginal distribution of education levels in the total population of Norway (c.f. Table 1). Separate weights were created for maternal and paternal education levels. For the population weights, we used information on education levels from Statistics Norway [36]. To account for the fact that the parents reported on 10-14-year-olds (and could possibly also have older children), we used information about education levels for adults aged 30–59. Weights were applied by use of iterative post-stratification (i.e. raking), matching marginal distributions of the survey sample to population margins and extreme weights were trimmed to the median weight plus 5 times the interquartile range of the weights [37,38]. Post-stratification weighting and analyses incorporating the weights were conducted with the R-packages ‘survey’ [39] and ‘srvyr’ [40] in R for Mac, version 3.5.3 [41]. Confidence intervals around prevalence estimates were calculated with the xlogit method [39]. The association between age, gender and their interaction on the prevalence of different main categories of disorder was tested using survey-weighted generalised linear models in the ‘survey’ package [39]. Prevalence estimates are reported for broader groups of disorders: any psychiatric disorders (all psychiatric diagnoses made), anxiety disorders, depressive disorders, ADHD and disruptive disorders (i.e., conduct disorder, oppositional defiant disorder, and other disruptive disorders). Estimates for specific disorders are presented in supplementary tables due to higher uncertainty in these estimates. When estimating age and gender-specific prevalence estimates, age was categorized into five approximately equally sized groups (n = 322–326) corresponding to the age intervals [10.4,11.7), [11.7,12.2), [12.2,12.8), [12.8,13.4) and [13.4,14.2]. To fully investigate the gender-specific influence of weighting on the prevalence estimates, we calculated gender specific correlations between parental education levels and psychiatric disorders, and we also investigated the distribution of psychiatric disorders according to parental education levels on the unweighted data (results available on request).

Table 1. Distribution of variables used for weighting the survey data.

DAWBA sample Population sample
% %
Maternal education
    Elementary 3.7 21.4
    High school 31.4 41.6
    Uni/college (<4 yrs) 33.1 28.9
    Uni/college (>4 yrs) 28.1 6.2
    Missing 3.7 2.0
Paternal education
    Elementary 7.0 20.5
    High school 29.6 47.8
    Uni/college (<4 yrs) 26.4 19.9
    Uni/college (>4 yrs) 31.2 9.5
    Missing 5.9 2.2

Representativeness of the DAWBA sample to the screening sample

The representativeness of the participants in the psychiatric assessment phase has been reported in a previous publication, where it was found that those who participated in the DAWBA were slightly younger, had better economic well-being, and had more highly educated parents compared to those participating in the questionnaire phase only [42]. There were minor differences in symptoms of mental health problems between participants in the questionnaire sample and the psychiatric assessment. A Welch two-sample t-test yielded significant differences in the means for SDQ Conduct problems and Hyperactivity/inattention, but effect sizes were very small [43]. There were no significant differences between the samples regarding the distribution of the SDQ total problems score; 9.5% of participants in the questionnaire sample and 8.4% of participants in the psychiatric assessment sample who scored above the 90th percentile (score >13), χ2(1) = .001, p = .969.

Results

In the population-weighted analyses, the prevalence of any psychiatric disorder was estimated to be 6.93% (95% CI 5.06–9.41). The most commonly made diagnoses were anxiety disorders, followed by disruptive disorders and ADHD, see Table 2. It was estimated that about 1% the sample had other psychiatric disorders, such as PDD/Autism and Tic disorder (see S1 Table). The estimated point prevalence rates were somewhat higher than in the analyses of the unweighted data.

Table 2. Prevalence of main categories of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study.

Unweighted1 Weighted to population2
% (n) 95% CI % 95% CI
Any psychiatric disorder 5.87 (80) 4.73–7.25 6.93 5.06–9.41
Any anxiety disorder 2.86 (39) 2.10–3.89 3.84 2.50–5.85
Any depressive disorder 0.44 (6) 0.20–0.98 0.64 0.16–2.58
Any ADHD 1.17 (16) 0.72–1.91 1.54 0.76–3.10
Any disruptive disorder 1.32 (18) 0.83–2.09 1.62 0.82–3.18

1DAWBA participants only.

2Weighted to population margins for education levels in the population.

Prevalence by gender and age

The prevalence of psychiatric disorders was estimated to be 7.52% (95% CI 4.68–11.86) for girls and 6.27% (95% CI 4.42–8.83) for boys in the gender stratified population-weighted analyses (c.f. Table 3). The most common diagnostic group, as indicated by the point prevalence estimate, was anxiety disorders, followed by disruptive disorders for boys and ADHD for girls. In the regression analyses, there was no evidence of male or female gender significantly predicting any of the major disorder categories (all p-values >.2 for anxiety, depression, ADHD, and disruptive disorders). The prevalence rates for all diagnoses are available in S2 Table.

Table 3. Prevalence of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study, by gender.

Unweighted1 Weighted to population2
Girls Boys Girls Boys
% 95% CI % 95% CI % 95% CI % 95% CI
Any psychiatric disorder 4.64 3.32–6.46 7.20 5.45–9.46 7.52 4.68–11.86 6.27 4.42–8.83
Any anxiety disorder 2.81 1.82–4.32 2.91 1.86–4.52 4.37 2.35–8.00 3.25 1.93–5.40
Any depressive disorder 0.56 0.21–1.49 0.31 0.08–1.22 1.13 0.25–4.96 0.09 0.02–0.38
Any ADHD 0.56 0.21–1.49 1.84 1.04–3.21 1.61 0.50–5.06 1.47 0.73–2.91
Any disruptive disorder 0.56 0.21–1.49 2.14 1.27–3.59 1.19 0.28–4.91 2.10 1.11–3.95

1DAWBA participants only.

2Weighted to population margins for education levels in the population.

The prevalence by age and gender for the broader disorder categories can be seen in Fig 2. The point prevalence of any psychiatric disorder was highest among the youngest participants, with anxiety disorders, ADHD and disruptive disorders being the most common diagnoses in this age group. Among the oldest participants, the point prevalence is lower, mainly including children with anxiety disorders and ADHD. Anxiety disorders were diagnosed in all age groups, depression mainly among 12.2–12.8-years-old, ADHD mainly among the youngest and oldest participants, whereas disruptive disorders were diagnosed in all age groups except among the 11.7–12.2-years-old. Due to the relatively few participants diagnosed, these age and gender-specific prevalence estimates were highly influenced by how the age-intervals were created. As indicated by the large and overlapping confidence intervals, age, nor its interaction with gender, did not significantly predict any of the major disorder categories (anxiety, depression, ADHD, and disruptive disorders) in the regression analyses, all p-values >.2.

Fig 2. Prevalence of main psychiatric disorders by age.

Fig 2

Population weighted estimates. Participant age (range 10.4–14.2 years) was categorized into five approximately equally sized intervals corresponding to the categories on the x-axis (n = 322–326). Error bars represent the 95% confidence intervals of the point prevalence.

For a different perspective on age-of onset and accumulation of psychiatric disorders, we also calculated the cumulative prevalence by age and gender in unweighted data, see Fig 3. The steepness of the slopes indicates at which age diagnoses accumulate. For any psychiatric disorder and anxiety disorders there appears to be a steady increase in diagnosed disorders with age. For anxiety disorders, more girls are diagnosed from around 13 years of age, and the cumulative number of females with anxiety disorders become higher than for males. For depressive disorders diagnoses start to accumulate for girls at around 12 years of age, and at a somewhat later age for boys. For ADHD and disruptive disorders, one accumulation appears between 11 and 12 years of age, and another between 13 and 14 years of age, but girls are diagnosed at a younger age.

Fig 3. Cumulative number of diagnosed participants by age.

Fig 3

Observed frequencies. The points represent the cumulative number of participants with a diagnosis at each age. The scales on the y-axis are free as the cumulative frequencies vary by psychiatric disorder.

Comorbidity

Within the major domains of mental health problems (emotional disorders [anxiety disorders and depressive disorders], conduct disorders and ADHD), 88.6% fulfilled the diagnostic criteria for a single disorder, and 11.4% of children fulfilled criteria for more than one diagnosis, illustrated with the Venn-diagram in Fig 4. The most common overlap was between conduct disorder and ADHD.

Fig 4. Venn diagram illustrating overlap between main diagnostic categories.

Fig 4

There were no children with comorbidity across all diagnostic categories. Anxiety and depressive disorders were collapsed into the category Emotional disorders for the purpose of producing this figure.

Discussion

The aim of the current study was to estimate prevalence rates for psychiatric disorders in Norwegian 10-14-year-olds. According to the population weighted interval estimate 5.06–9.41% of participants met DSM-IV criteria for a psychiatric disorder, with emotional disorders being most prevalent, followed by ADHD and conduct disorders. There were no suggestions of strong gender and age effects on the prevalence estimates.

Prevalence of psychiatric disorders

The point prevalence estimates for any psychiatric disorders obtained in this study, and in the previous study of younger children [10] is relatively low compared to most international studies [11]. The upper confidence interval for the estimate is 1.3% lower than the lowest interval estimate reported for any psychiatric disorder in the recent review by Polanczyk et al [11]. For specific disorder categories, the interval estimates for anxiety disorders (2.50–5.85), depressive disorders (0.16–2.58) and ADHD (0.76–3.10) overlap with interval estimates previously reported [11]. The prevalence of disruptive disorders (0.76–3.10), and specifically oppositional defiant disorder (0.19–2.56) are also close to intervals previously reported [11]. For conduct disorder (0.07–0.81), the upper interval estimate obtained in the current study is about 1% lower than the lowest interval estimate reported by Polanczyk et al [11].

The relatively low prevalence rates presented here could be related to methodological issues such as the sampling procedure and choice of diagnostic instrument. Participants were recruited through schools, a sampling frame which may exclude high-risk groups (e.g., sick or disabled children). Still, the DAWBA was completed on-line by parents which may lower the risk of non-participation by high-risk children. The choice of diagnostic instrument has been found to strongly influence prevalence estimates [11]. The time frame of the DAWBA is ‘current’, which may produce lower prevalence rates compared to other instruments with a wider time frame (e.g., the time frame for CAPA is 3 months, 6 months for DISC, and 1 year for CIDI). In a study where different instruments (the DISC, CAPA, and DAWBA) were used to make diagnoses on the same sample of 1,200 children and adolescents, the DAWBA made only half the number of DSM-IV diagnoses compared to the other instruments [44].

These lower prevalence rates could also be indicative of real and substantial differences in the prevalence of psychiatric disorders between countries. Other studies from Scandinavia have reported low prevalence of parent reported symptoms of mental disorders when using checklists [1517], but also when diagnostic instruments were used [10,18]. A study comparing externalizing disorders in the current sample with a sample of children from the UK also found lower scores for externalizing disorders, and this difference was not explained by reporting style [45]. The reasons for the lower prevalence estimates are not obvious. It may be related to the relatively low poverty rates and relatively small income inequalities in Norway [46], to the relatively high education levels in the population [47], or to low unemployment rates [47]. More positive attitudes towards people with mental health disorders [48] may also influence whether certain behaviours are “normalized” or reported as problematic symptoms. However, in a study where rates between the UK and Norway were compared, no evidence for such reporting bias could be demonstrated for DAWBA diagnoses [45]. Further, universal health care and school mental health services may be related to early intervention and prevention of mental health problems [49], and the cultural context may create different exposure to risk and protective factors for the population [50].

Gender and age differences

The prevalence of any psychiatric disorders was about as frequent among boys and girls. There was considerable overlap in the confidence intervals for the prevalence estimates for males and females, and the lack of strong gender differences was confirmed by gender being a non-significant predictor for all the major categories of psychiatric disorders in the regression analyses. The gender-specific prevalence intervals estimated in the current study are within intervals previously reported for anxiety disorders and ADHD [13,21]. For girls, the prevalence estimates for depression, conduct disorder and oppositional defiant disorder in the current study are also in line with previous reports, but the prevalence of conduct disorder and depressive disorders for boys are lower [13,21].

The gender specific associations were mostly in the expected directions as indicated by the point prevalence estimates, but the imprecision related to low number of diagnosed participants produced wide and overlapping confidence intervals. Anxiety disorders was higher for girls (girls [g]: boys [b] ratio: 1.3:1) as indicated by the point prevalence. We expected a female preponderance of anxiety disorders at this age, in line with several previous studies [13,51,52]. The point prevalence of depressive disorders was also higher for girls compared to boys (g:b ratio: 13:1). A higher rate of depressive disorders among girls was as predicted, as the age of the current sample corresponds well with the age when more females than males develop depressive disorders [5355]. The point prevalence of disruptive disorders was higher for boys than for girls (b:g ratio: 1.8:1). This result is in line with previous reviews were disruptive disorders have been found to be 1.6–3.1 times more common among males than females [21,22]. An unexpected finding was that the point prevalence of ADHD was relatively similar for boys and girls, even slightly more common among girls (g:b ratio: 1.1:1). This is contrast to results reported in a previous review, where the prevalence of ADHD was estimated to be 3.2–4.7 times higher for male compared to female 5-19-year-olds. In the unweighted analyses in the current study, the male to female ratio was more in line with previous studies (b:g ratio 3.2:1 for ADHD), suggesting there were some unanticipated effects associated with the population weighting for this disorder.

In general, there were gender-specific effects related to applying population weights. With the exception of anxiety disorders, population weighting was associated with an increase in prevalence for girls, and a reduction in prevalence for boys. Analyses of these affects suggested that for some disorders the correlations with parental education levels went in the opposite direction for boys and girls. We also found a stronger association between low parental education levels and prevalence of some disorders for girls compared to boys. However, the results remained essentially unchanged with regards to gender differences, as the prevalence intervals overlapped also in the unweighted data. Still, these gender-specific associations between disorders and parental education levels may be specific to this sample and should be taken into consideration when interpreting the results from the current study.

The prevalence of psychiatric disorders was not significantly higher at any particular age. Age was a non-significant predictor in the regression analyses, and the prevalence intervals of any psychiatric disorders were overlapping for the youngest and oldest participants. Although the point prevalence was highest for the younger participants, it was highly variable within each age interval. This is consistent with previous studies [13] but may also reflect the few participants diagnosed within some age-intervals. There was evidence of psychiatric disorders accumulating with increasing age, but there was no consistent pattern in the prevalence of disorders in each age-group.

Strengths and limitations

Among the strengths of the current study are the relatively large sample size, the use of a complete clinician-rated semi-structured interview for establishing psychiatric diagnoses, and the use of post-stratification weights to counter bias related to selective participation.

Some limitations should be taken into account when interpreting the results from this study. One limitation relates to the statistical uncertainty related to few participants being diagnosed which may lead to sample specific arrangements of gender, disorders and parental education levels. Weighting may have amplified these combinations, in particular affecting prevalence estimates for disorders with few participants.

Furthermore, reweighing for non-response implicitly implies a conceptualization of missing data mechanisms [56]. The auxiliary variables available in the current study were parental education levels, so weights by design only address non-response related to parental education levels. Other variables, either where population information is unavailable (e.g., screening scores for mental health problems) or that were not included in the current survey (e.g., household income), may also be predictive of non-response [28].

Another limitation may be related to the lack of self-reported information from children. However, studies have not found additional informants to produce significantly different prevalence rates [11].

Finally, the data for this study was gathered in 2006, and may therefore not reflect current prevalence rates in the population. Our results, however, are consistent with studies of Norwegian children that have been conducted both earlier [10] and later [18], suggesting stability in the prevalence of mental health disorders in the child population. Temporal stability in prevalence was also suggested by a recent review [11], where year of data collection (ranging from 1985 to 2012) was non-significantly associated with prevalence rates of mental health disorders. Still, more recent changes, such as increases in child poverty [57] and the common use of social media with potential implications for mental health [58] underscores the need for updated prevalence estimates.

Conclusion

In line with previous studies from Scandinavia, the prevalence of psychiatric disorders was found to be relatively low in this sample of Norwegian children. Given the high worldwide prevalence and burden of disease of mental disorders, these findings raise important scientific questions for future research into why populations in some societies show lower rates of mental health problems than others. The findings also suggest that collapsing prevalence estimates across larger regions (such as e.g., Europe), may hide geographical variation which in turn could inform hypotheses about the causes of this variation. The findings from the current study also underscores the utility of epidemiological studies in providing precise information needed for planning and scaling preventive and interventive services.

Supporting information

S1 Table. Prevalence of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study.

(DOCX)

S2 Table. Prevalence of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study, by gender.

(DOCX)

Data Availability

Data cannot be shared publicly due to privacy restrictions in accordance with the ethical approval for the Bergen Child Study. Norwegian Health research legislation and the Norwegian Ethics committees require explicit consent from participants in order to transfer health research data outside of Norway. In this specific case, ethics approval is also contingent on storing the research data on secure storage facilities located in our research institution. Data are from the Norwegian Bergen Child Study, owned by NORCE Norwegian Research Centre. The authors did not have special access privileges to data from the survey. Data are available from the the Bergen Child Study Institutional Data Access (contact via bib@norceresearch.no) for researchers who meet the criteria for access to confidential data.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Erskine HE, Moffitt TE, Copeland WE, et al. (2015) A heavy burden on young minds: The global burden of mental and substance use disorders in children and youth. Psychol Med 45:1551–1563. 10.1017/S0033291714002888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Copeland WE, Shanahan L, Costello EJ, Angold A (2009) Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 66:764–772. 10.1001/archgenpsychiatry.2009.85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Erskine HE, Baxter AJ, Patton G, et al. (2017) The global coverage of prevalence data for mental disorders in children and adolescents. Epidemiol Psychiatr Sci 26:395–402. 10.1017/S2045796015001158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Atladottir HO, Gyllenberg D, Langridge A, et al. (2015) The increasing prevalence of reported diagnoses of childhood psychiatric disorders: A descriptive multinational comparison. Eur Child Adolesc Psychiatry 24:173–183. 10.1007/s00787-014-0553-8 [DOI] [PubMed] [Google Scholar]
  • 5.Hansen SN, Schendel DE, Parner ET (2015) Explaining the increase in the prevalence of autism spectrum disorders: The proportion attributable to changes in reporting practices. JAMA Pediatr 169:56–62. 10.1001/jamapediatrics.2014.1893 [DOI] [PubMed] [Google Scholar]
  • 6.Lundström S, Reichenberg A, Anckarsäter H, et al. (2015) Autism phenotype versus registered diagnosis in Swedish children: Prevalence trends over 10 years in general population samples. BMJ 350:h1961. 10.1136/bmj.h1961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jacobsen TN, Nohr EA, Frydenberg M (2010) Selection by socioeconomic factors into the Danish National Birth Cohort. Eur J Epidemiol 25:349–355. 10.1007/s10654-010-9448-2 [DOI] [PubMed] [Google Scholar]
  • 8.Madsen KB, Hohwü L, Zhu JL, et al. (2017) Social selection in cohort studies and later representation of childhood psychiatric diagnoses: The Danish National Birth Cohort. Scand J Public Health 1403494817726619. 10.1177/1403494817726619 [DOI] [PubMed] [Google Scholar]
  • 9.Meltzer H, Gatward R, Goodman R, Ford T (2003) Mental health of children and adolescents in Great Britain. Int Rev Psychiatry 15:185–187. 10.1080/0954026021000046155 [DOI] [PubMed] [Google Scholar]
  • 10.Heiervang E, Stormark KM, Lundervold AJ, et al. (2007) Psychiatric disorders in Norwegian 8- to 10-year-olds. J Am Acad Child Adolesc Psychiatry 46:438–447. 10.1097/chi.0b013e31803062bf [DOI] [PubMed] [Google Scholar]
  • 11.Polanczyk GV, Salum GA, Sugaya LS, et al. (2015) Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry Allied Discip 56:345–365. 10.1111/jcpp.12381 [DOI] [PubMed] [Google Scholar]
  • 12.Georgiades K, Duncan L, Wang L, et al. (2019) Six-Month Prevalence of Mental Disorders and Service Contacts among Children and Youth in Ontario: Evidence from the 2014 Ontario Child Health Study. Can J Psychiatry 64:246–255. 10.1177/0706743719830024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Costello EJ, Mustillo S, Erkanli A, et al. (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837. 10.1001/archpsyc.60.8.837 [DOI] [PubMed] [Google Scholar]
  • 14.Sawyer SM, Afifi RA, Bearinger LH, et al. (2012) Adolescence: A foundation for future health. The Lancet 379:1630–1640. 10.1016/S0140-6736(12)60072-5 [DOI] [PubMed] [Google Scholar]
  • 15.Obel C, Heiervang E, Rodriguez A, et al. (2004) The strengths and difficulties questionnaire in the nordic countries. Eur Child Adolesc Psychiatry Suppl 13:II32–9. 10.1007/s00787-004-2006-2 [DOI] [PubMed] [Google Scholar]
  • 16.Reedtz C, Bertelsen B, Lurie J, et al. (2008) Eyberg Child Behavior Inventory (ECBI): Norwegian norms to identify conduct problems in children. Scand J Psychol 49:31–38. 10.1111/j.1467-9450.2007.00621.x [DOI] [PubMed] [Google Scholar]
  • 17.Rescorla L, Achenbach T, Ivanova MY, et al. (2007) Behavioral and Emotional Problems Reported by Parents of Children Ages 6 to 16 in 31 Societies. Journal of Emotional and Behavioral Disorders 15:130–142. https://doi.org/10/cpwvjr. [Google Scholar]
  • 18.Wichstrom L, Berg-Nielsen TS, Angold A, et al. (2012) Prevalence of psychiatric disorders in preschoolers. Journal of child psychology and psychiatry, and allied disciplines 53:695–705. 10.1111/j.1469-7610.2011.02514.x [DOI] [PubMed] [Google Scholar]
  • 19.Polanczyk G, de Lima MS, Horta BL, et al. (2007) The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942–948. 10.1176/ajp.2007.164.6.942 [DOI] [PubMed] [Google Scholar]
  • 20.Willcutt EG (2012) The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. Neurotherapeutics 9:490–499. 10.1007/s13311-012-0135-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Erskine HE, Ferrari AJ, Nelson P, et al. (2013) Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. J Child Psychol Psychiatry 54:1263–1274. 10.1111/jcpp.12144 [DOI] [PubMed] [Google Scholar]
  • 22.Demmer DH, Hooley M, Sheen J, et al. (2017) Sex Differences in the Prevalence of Oppositional Defiant Disorder During Middle Childhood: A Meta-Analysis. J Abnorm Child Psychol 45:313–325. 10.1007/s10802-016-0170-8 [DOI] [PubMed] [Google Scholar]
  • 23.Merikangas KR, He J-p, Burstein M, et al. (2010) Lifetime prevalence of mental disorders in u.s. Adolescents: Results from the national comorbidity survey replicationAdolescent supplement (ncs-a). J Am Acad Child Adolesc Psychiatry 49:980–989. 10.1016/j.jaac.2010.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rozzell K, Moon DY, Klimek P, et al. (2019) Prevalence of Eating Disorders Among US Children Aged 9 to 10 Years: Data From the Adolescent Brain Cognitive Development (ABCD) StudyPrevalence of Eating Disorders Among US Preadolescent ChildrenLetters. JAMA Pediatr 173:100–101. 10.1001/jamapediatrics.2018.3678 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Reiss F (2013) Socioeconomic inequalities and mental health problems in children and adolescents: A systematic review. Soc Sci Med 90:24–31. 10.1016/j.socscimed.2013.04.026 [DOI] [PubMed] [Google Scholar]
  • 26.Bøe T, Dearing E, Stormark K, Zachrisson H (2016) Feeling poor versus being poor in Norway Associations to adolescent mental health: Tormod Bøe. Eur J Public Health 26:ckw164–040. https://doi.org/10/gf56p6. [Google Scholar]
  • 27.Bøe T, Øverland S, Lundervold AJ, Hysing M (2012) Socioeconomic status and children’s mental health: Results from the Bergen Child Study. Soc Psychiatry Psychiatr Epidemiol 47:1557–66. 10.1007/s00127-011-0462-9 [DOI] [PubMed] [Google Scholar]
  • 28.Reinikainen J, Tolonen H, Borodulin K, et al. (2018) Participation rates by educational levels have diverged during 25 years in Finnish health examination surveys. Eur J Public Health 28:237–243. 10.1093/eurpub/ckx151 [DOI] [PubMed] [Google Scholar]
  • 29.Cheung KL, ten Klooster PM, Smit C, et al. (2017) The impact of non-response bias due to sampling in public health studies: A comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health. BMC Public Health 17:276. 10.1186/s12889-017-4189-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lorant V, Demarest S, Miermans P-J, Van Oyen H (2007) Survey error in measuring socio-economic risk factors of health status: A comparison of a survey and a census. Int J Epidemiol 36:1292–1299. 10.1093/ije/dym191 [DOI] [PubMed] [Google Scholar]
  • 31.Goodman R, Ford T, Richards H, et al. (2000) The development and well-being assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry 41:S0021963099005909. https://doi.org/10/bk5p2n. [PubMed] [Google Scholar]
  • 32.Goodman R (1997) The strengths and difficulties questionnaire: A research note. J Child Psychol Psychiatry Allied Discip 38:581–586. 10.1111/j.1469-7610.1997.tb01545.x [DOI] [PubMed] [Google Scholar]
  • 33.Goodman R (1999) The Extended Version of the Strengths and Difficulties Questionnaire as a Guide to Child Psychiatric Caseness and Consequent Burden. Journal of Child Psychology and Psychiatry 40:791–799. https://doi.org/10/dk7tcs. [PubMed] [Google Scholar]
  • 34.Goodman A, Heiervang E, Collishaw S, Goodman R (2011) The “DAWBA bands” as an ordered-categorical measure of child mental health: Description and validation in British and Norwegian samples. Soc Psychiatry Psychiatr Epidemiol 46:521–532. 10.1007/s00127-010-0219-x [DOI] [PubMed] [Google Scholar]
  • 35.Heiervang E, Goodman R (2011) Advantages and limitations of web-based surveys: Evidence from a child mental health survey. Soc Psychiatry Psychiatr Epidemiol 46:69–76. 10.1007/s00127-009-0171-9 [DOI] [PubMed] [Google Scholar]
  • 36.Statistics Norway (2018) Educational attainment of the population.
  • 37.de Kerckhove WV, Mohadjer L, Krenzke T (2014) A Weight-Trimming Approach to Achieve a Comparable Increase to Bias Across Countries in the Programme for the International Assessment of Adult Competencies. In: JSM. p 12. [Google Scholar]
  • 38.Potter F (1990) A Study of Procedures to Identify and Trim Extreme Sampling Weights. In: Section on Survey Research Methods, American Statistical Association, pp 225–230. [Google Scholar]
  • 39.Lumley T (2019) Survey: Analysis of complex survey samples. [Google Scholar]
  • 40.Ellis GF (2019) Srvyr: ‘Dplyr’-Like Syntax for Summary Statistics of Survey Data. [Google Scholar]
  • 41.R Core Team (2019) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; R Foundation for Statistical Computing, Vienna, Austria. [Google Scholar]
  • 42.Bøe T, Serlachius AS, Sivertsen B, et al. (2017) Cumulative effects of negative life events and family stress on children’s mental health: The Bergen child study. Soc Psychiatry Psychiatr Epidemiol 1–9. 10.1007/s00127-017-1451-4 [DOI] [PubMed] [Google Scholar]
  • 43.Sawilowsky SS (2009) New Effect Size Rules of Thumb. J Mod App Stat Meth 8:597–599. https://doi.org/10/gfz8r6. [Google Scholar]
  • 44.Angold A, Erkanli A, Copeland W, et al. (2012) Psychiatric Diagnostic Interviews for Children and Adolescents: A Comparative Study. Journal of the American Academy of Child & Adolescent Psychiatry 51:506–517. https://doi.org/10/gghvwh. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Heiervang E, Goodman A, Goodman R (2008) The nordic advantage in child mental health: Separating health differences from reporting style in a cross-cultural comparison of psychopathology. J Child Psychol Psychiatry Allied Discip 49:678–685. https://doi.org/10/bk34n2. [DOI] [PubMed] [Google Scholar]
  • 46.Center UIR (2012) Report card 10: Measuring child poverty. New league tables of child poverty in the world’s richest coutries. UNICEF Innocenti Research Center, Florence, It. [Google Scholar]
  • 47.OECD (2019) Education at a glance 2019: Norway. OECD Publishing, Paris. [Google Scholar]
  • 48.European Commission. (2006) Mental Well-being. EC Directorate General Communication.
  • 49.Kieling C, Baker-Henningham H, Belfer M, et al. (2011) Child and adolescent mental health worldwide: Evidence for action. The Lancet 378:1515–1525. 10.1016/S0140-6736(11)60827-1 [DOI] [PubMed] [Google Scholar]
  • 50.Canino G, Alegría M (2008) Psychiatric diagnosis is it universal or relative to culture? J Child Psychol Psychiatry 49:237–250. 10.1111/j.1469-7610.2007.01854.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Essau CA, Conradt J, Petermann F Frequency, comorbidity, and psychosocial impairment of anxiety disorders in German adolescents. J Anxiety Disord 14:263–279. 10.1016/s0887-6185(99)00039-0 [DOI] [PubMed] [Google Scholar]
  • 52.Baxter AJ, Scott KM, Vos T, Whiteford HA (2013) Global prevalence of anxiety disorders: A systematic review and meta-regression. Psychol Med 43:897–910. 10.1017/S003329171200147X [DOI] [PubMed] [Google Scholar]
  • 53.Twenge JM, Nolen-Hoeksema S (2002) Age, gender, race, socioeconomic status, and birth cohort difference on the children’s depression inventory: A meta-analysis. J Abnorm Psychol 111:578–588. 10.1037//0021-843x.111.4.578 [DOI] [PubMed] [Google Scholar]
  • 54.Saluja G, Iachan R, Scheidt PC, et al. (2004) Prevalence of and Risk Factors for Depressive Symptoms Among Young Adolescents. Arch Pediatr Adolesc Med 158:760–765. 10.1001/archpedi.158.8.760 [DOI] [PubMed] [Google Scholar]
  • 55.Brooks TL, Harris SK, Thrall JS, Woods ER (2002) Association of adolescent risk behaviors with mental health symptoms in high school students. J Adolesc Health 31:240–246. 10.1016/s1054-139x(02)00385-3 [DOI] [PubMed] [Google Scholar]
  • 56.Lumley TS (2010) Complex Surveys: A Guide to Analysis Using R. John Wiley & Sons, New Jersey. [Google Scholar]
  • 57.OECD (2018) Poor children in rich countries: Why we need policy action. OECD Publishing, Paris. [Google Scholar]
  • 58.Keles B, McCrae N, Grealish A (2020) A systematic review: The influence of social media on depression, anxiety and psychological distress in adolescents. International Journal of Adolescence and Youth 25:79–93. https://doi.org/10/gfxf4k. [Google Scholar]

Decision Letter 0

Ehsan U Syed

23 Oct 2020

PONE-D-20-25358

Prevalence of Psychiatric Disorders in Norwegian 10-14-Year-Olds: Results from a cross-sectional study

PLOS ONE

Dear Dr. Tormod Boe

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 07 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Ehsan U Syed, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for including your ethics statement:  "The study was approved by the Regional Committee for Medical Research Ethics in Western Norway (approval number 062-06) and by the National Data Inspectorate.".   

Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

4. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).

5.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this paper "Prevalence of Psychiatric Disorders in Norwegian 10-14 Year-Olds". In this paper, The aim of this study to find prevalence of psychiatric disorders in a Norwegian population-based sample of early adolescent boys and girl. Authors have highlighted limitation of official clinical and administrative registries. Authors also reported prevalence of psychiatric disorder in same cohort between age 7-9 years old in the previous study. I have following concerns about this study.

Method section:

One of the major limitation of this study only 24% completed the full assessment (DAWDA), while this population base study - but only 1/4 completed the assessment and also who completed have more parents education. Authors already reported that about lower socioeconomic status are under-represented as limitation of administrative registry. So how this sample is more representative?

2nd paragraph, authors report that teachers data from the screening phase is not included. However, in abstract and next paragraph (DAWBA was administered through a web-based system, and parents and teachers provided information), and psychiatric assessment section: authors report teacher report was included.

What the rationale of dividing the groups in so close age range? [10.4,11.7), [11.7,12.2), [12.2,12.8), [12.8,13.4) and [13.4,14.2].

Discussion section:

Authors reports low prevalence related to methodological issues as sampling procedure and choice of diagnostic instrument. If we have same issues with this study - how it is better and adding to what we already know?

Authors also reports that low prevalence may be related to DAWDA time frame "current". However, ADHD is chronic psychiatric disorder and anxiety could be also pervasive in childhood ; so how it is different CAPA, DISC or CIDI. Current time frame in DAWDA is also very vague. Authors themselves highlighted the limitation of DAWBA (....only half the number of DSM-IV diagnoses compared to the other instruments [44]). Knowing that this scale have limitation = not sure how this study is representative of population based prevalence of psychiatric disorder.

Minor issues :

2nd paragraph (discussion gender and age difference): Anxiety disorders was higher for girls for anxiety disorders (anxiety disorder twice in a same sentence).

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 19;16(3):e0248864. doi: 10.1371/journal.pone.0248864.r002

Author response to Decision Letter 0


10 Feb 2021

To Editor-in-chief, PLOS ONE.

We would like to thank you for the opportunity to revise our manuscript. Below you will find our responses to the reviewer’s concerns, our responses in italics. We have uploaded a marked copy of our manuscript, as well as an unmarked version to the submission system, accompanying this rebuttal letter.

We would also like to thank the academic editor for extending the deadline for resubmission of our manuscript.

Yours sincerely,

Tormod Bøe, PhD

On behalf of all authors.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have now updated the manuscript according to the PLOS ONE style requirements.

2.Thank you for including your ethics statement: "The study was approved by the Regional Committee for Medical Research Ethics in Western Norway (approval number 062-06) and by the National Data Inspectorate.".

Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

(…)

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

We have now updated the ethics statement in the manuscript, and in the “Ethics statement” field of the submission form. The revised statement now reads:

"The study was approved by the Regional Committee for Medical Research Ethics in Western Norway (approval number 062-06) and by the National Data Inspectorate. Participants gave written informed consent and parents and guardians consented on behalf of their children".

3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

We apologize for this error; titles are now identical in the submission form and in the manuscript.

4. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary).

The list of author affiliations has been updated.

5.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

We have updated the Data availability statement to detail the legal restrictions regarding sharing of the data set and also provide this information in the cover letter. The data availability statement now reads:

“Data cannot be shared publicly due to privacy restrictions in accordance with the ethical approval for the Bergen Child Study. Norwegian Health research legislation and the Norwegian Ethics committees require explicit consent from participants in order to transfer health research data outside of Norway. In this specific case, ethics approval is also contingent on storing the research data on secure storage facilities located in our research institution. Data are from the Norwegian Bergen Child Study, owned by NORCE Norwegian Research Centre. The authors did not have special access privileges to data from the survey. Data are available from the Bergen Child Study (contact via bib@norceresearch.no) for researchers who meet the criteria for access to confidential data.”

Reviewers' comments:

Reviewer #1: In this paper "Prevalence of Psychiatric Disorders in Norwegian 10-14 Year-Olds". In this paper, The aim of this study to find prevalence of psychiatric disorders in a Norwegian population-based sample of early adolescent boys and girl. Authors have highlighted limitation of official clinical and administrative registries. Authors also reported prevalence of psychiatric disorder in same cohort between age 7-9 years old in the previous study. I have following concerns about this study.

Method section:

One of the major limitations of this study only 24% completed the full assessment (DAWDA), while this population base study - but only 1/4 completed the assessment and also who completed have more parents education. Authors already reported that about lower socioeconomic status are under-represented as limitation of administrative registry. So how this sample is more representative?

In the authors’ opinions, the strength of the current study is the use of weighting to counter the selective participation by higher educated participants commonly seen in previous literature. By using weights, we use the information about those not participating to estimate what the prevalence would have been if all participants had completed the clinical interview.

2nd paragraph, authors report that teacher’s data from the screening phase is not included. However, in abstract and next paragraph (DAWBA was administered through a web-based system, and parents and teachers provided information), and psychiatric assessment section: authors report teacher report was included.

This is correct. Teacher data was not included in the screening phase (see Figure 1), but it was included in the psychiatric assessment phase. In the current study, information from the screening phase is used for weighting (parental education levels, reported by parents) and to indicate representativeness of the sample participating in the psychiatric assessment to the full sample (results described under own heading on page 5).

What the rationale of dividing the groups in so close age range? [10.4,11.7), [11.7,12.2), [12.2,12.8), [12.8,13.4) and [13.4,14.2].

The rationale for dividing the age groups in this way were to provide a detailed perspective on the prevalence of different disorders across this narrow age span. As discussed, (p. 6) the prevalence was highly variable depending on how age was categorized, and we therefore also report the main effects of (uncategorized) age (and its interaction with gender) in the manuscript (pp. 6-7).

Discussion section:

Authors reports low prevalence related to methodological issues as sampling procedure and choice of diagnostic instrument. If we have same issues with this study - how it is better and adding to what we already know?

As detailed above, the weighting procedure used in the current study is aimed at alleviating problems with sampling procedures from previous studies. Regarding the use of DAWBA, this is merely a point to consider when interpreting the results from the current study, and when comparing and contrasting this study to previous studies where different instruments may have been used.

Authors also reports that low prevalence may be related to DAWDA time frame "current". However, ADHD is chronic psychiatric disorder and anxiety could be also pervasive in childhood ; so how it is different CAPA, DISC or CIDI. Current time frame in DAWDA is also very vague. Authors themselves highlighted the limitation of DAWBA (....only half the number of DSM-IV diagnoses compared to the other instruments [44]). Knowing that this scale have limitation = not sure how this study is representative of population based prevalence of psychiatric disorder.

There is no particular threat to the validity of the current study in light of having used the DAWBA as a diagnostic tool. The different time frame may, however, be useful to be aware of when comparing and contrasting prevalence estimates from different studies where other instruments and time frames may have been used. There is no reason to expect that the current estimates are more or less valid than previous estimates.

Minor issues :

2nd paragraph (discussion gender and age difference): Anxiety disorders was higher for girls for anxiety disorders (anxiety disorder twice in a same sentence).

Thank you for noticing this error. We have now corrected this sentence in the manuscript (page 9).

Attachment

Submitted filename: rebuttal.docx

Decision Letter 1

Ehsan U Syed

8 Mar 2021

Prevalence of Psychiatric Disorders in Norwegian 10-14-Year-Olds: Results from a cross-sectional study

PONE-D-20-25358R1

Dear Dr. Boe

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ehsan U Syed, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Ehsan U Syed

10 Mar 2021

PONE-D-20-25358R1

Prevalence of Psychiatric Disorders in Norwegian 10-14-Year-Olds: Results from a cross-sectional study

Dear Dr. Bøe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ehsan U Syed

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Prevalence of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study.

    (DOCX)

    S2 Table. Prevalence of DSM-IV disorders among 10-14-year-old participants in the Bergen Child Study, by gender.

    (DOCX)

    Attachment

    Submitted filename: rebuttal.docx

    Data Availability Statement

    Data cannot be shared publicly due to privacy restrictions in accordance with the ethical approval for the Bergen Child Study. Norwegian Health research legislation and the Norwegian Ethics committees require explicit consent from participants in order to transfer health research data outside of Norway. In this specific case, ethics approval is also contingent on storing the research data on secure storage facilities located in our research institution. Data are from the Norwegian Bergen Child Study, owned by NORCE Norwegian Research Centre. The authors did not have special access privileges to data from the survey. Data are available from the the Bergen Child Study Institutional Data Access (contact via bib@norceresearch.no) for researchers who meet the criteria for access to confidential data.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES